PPA overview

Contract model and parties

Model:

Physical (on-site)

Generator:

Mitsubishi HC Capital Energy Inc.

三菱HCキャピタルエナジー株式会社

Offtaker:

ASKA Pharmaceutical

あすか製薬株式会社

Industry:

Pharmaceutical Manufacturing

Capacity and generation

T&D area:

Tohoku

Technology:

Solar

Capacity:

-

Inverter:

-

Generation:

Status and timeline

Status:

Live

*

Disclosed:

June 19, 2023

COD:

2024 spring (expected)

Duration:

Undisclosed

* Presumed live based on the expected COD.

Additional details

  • Mitsubishi HC Capital Energy will set up a solar power plant at ASKA Pharmaceutical Iwaki Factory
  • The PPA is expected to result in approximately 440t annual reduction of CO2 emissions

Mitsubishi HC Capital Energy Inc.'s other PPAs

ASKA Pharmaceutical's other PPAs

Japan Energy Hub PPA Report

Submit the form to register CPPAs in 2025: Market Overview, Trends and Opportunities report’s “early bird” pricing.

Monthly Report - The Japanese Power Industry Executive

Submit the form below to receive a sample issue of The Japan Power Industry Executive.